So far, the largest risk understood by doctors is linked to BPC-157s angiogenesis and cancer risk
[20] [21] Men with pre-existing retinopathy should be monitored appropriately
The BPC-157 sequence is a partial fragment of a larger gastric protein, Body Protection Compound, first characterised in published research in the 1990s
Transdermal patches can be an easy, effective way to receive medication
But serious side effects like allergic reactions are rare
This problem creates multiple risk layers: contamination with endotoxins, microbes, or unexpected compounds incorrect dosing from mislabeling or inconsistent concentration degradation due to poor storage or shipping unpredictable reactions that are not truly side effects but quality failures If you want a clear explanation of why this matters, read: The Dangers of Buying Research Pharmacy Peptides